scholarly journals Sexual Abuse in Irritable Bowel Syndrome: To Ask or Not to Ask – That Is the Question

2002 ◽  
Vol 16 (11) ◽  
pp. 801-805 ◽  
Author(s):  
Alexandra Ilnyckyj ◽  
Charles N Bernstein

BACKGROUND: Irritable bowel syndrome (IBS) is a common and costly disorder in Canada. The paucity of medical treatment underscores the importance of examining every element of the management approach. Data exist supporting an increased prevalence of abuse among individuals with IBS. Importantly, the pathophysiology underlying the link between abuse and IBS is increasingly understood. Treatment recommendations by opinion leaders support an abuse inquiry. However, many clinicians view abuse inquiry as an ethical dilemma.METHOD: Canadian gastroenterologists were surveyed to determine current practice patterns and to identify barriers to inquiry. Barriers cited by clinicians were explored within an ethical context.RESULTS: Abuse inquiry is not universally practised in Canada. Fifty-four per cent of the membership of Canadian Association of Gastroenterologists responded to the survey. They reported inquiring into abuse histories in approximately 50% of patients with IBS. The frequency of inquiry declined when male patients were considered. The primal barriers cited were time constraints (25%), personal comfort with abuse issues (25%) and lack of resources for addressing the abuse (33%). Importantly, only a minority (10%), cited abuse history as irrelevant to the management of the patient.INTERPRETATION: Physicians identify significant barriers to pursuing an inquiry into abuse. However, a minority cited ‘clinical irrelevance’ as a primal barrier, the implicit statement being that the abuse history has clinical relevance. This view is consistent with opinion leaders and published treatment recommendations. Therefore, by not inquiring into the abuse history, physicians are not fulfilling their ethical responsibility to the patient. Physicians need to resolve their barriers to inquiry. Furthermore, they need to familiarize themselves with treatment recommendations and include this review in their consultation.

2007 ◽  
Vol 21 (suppl b) ◽  
pp. 3B-22B ◽  
Author(s):  
Pierre Paré ◽  
Ronald Bridges ◽  
Malcolm C Champion ◽  
Subhas C Ganguli ◽  
James R Gray ◽  
...  

While chronic constipation (CC) has a high prevalence in primary care, there are no existing treatment recommendations to guide health care professionals. To address this, a consensus group of 10 gastroenterologists was formed to develop treatment recommendations. Although constipation may occur as a result of organic disease, the present paper addresses only the management of primary CC or constipation associated with irritable bowel syndrome. The final consensus group was assembled and the recommendations were created following the exact process outlined by the Canadian Association of Gastroenterology for the following areas: epidemiology, quality of life and threshold for treatment; definitions and diagnostic criteria; lifestyle changes; bulking agents and stool softeners; osmotic agents; prokinetics; stimulant laxatives; suppositories; enemas; other drugs; biofeedback and behavioural approaches; surgery; and probiotics. A treatment algorithm was developed by the group for CC and constipation associated with irritable bowel syndrome. Where possible, an evidence-based approach and expert opinions were used to develop the statements in areas with insufficient evidence. The nature of the underlying pathophysiology for constipation is often unclear, and it can be tricky for physicians to decide on an appropriate treatment strategy for the individual patient. The myriad of treatment options available to Canadian physicians can be confusing; thus, the main aim of the recommendations and treatment algorithm is to optimize the approach in clinical care based on available evidence.


2017 ◽  
Vol 11 (1) ◽  
Author(s):  
Motoko Ida ◽  
Akito Nishida ◽  
Hiraku Akiho ◽  
Yoshihiro Nakashima ◽  
Kei Matsueda ◽  
...  

Gut ◽  
1997 ◽  
Vol 41 (5) ◽  
pp. 669-674 ◽  
Author(s):  
H E van der Horst ◽  
A M van Dulmen ◽  
F G Schellevis ◽  
J Th M van Eijk ◽  
J F M Fennis ◽  
...  

Background—Little is known about the comparability of outpatients with irritable bowel syndrome (IBS) and patients with IBS in primary care with regard to severity of complaints, perceived limitations, other aspects of the complaints, and sex differences.Aims—To compare outpatients with IBS with primary care patients with IBS.Patients—One hundred and nine patients with IBS were recruited from general practices in Amsterdam and 86 patients with IBS were recruited from the outpatient clinic of the Department of Internal Medicine of the University Hospital in Nijmegen.Methods—Each patient completed a questionnaire on demographic variables, abdominal complaints, related complaints, and attributed causes of their abdominal complaints. The scores of the two groups were compared by univariate and multivariate analysis.Results—The outpatient group contained significantly more men, reported more severe abdominal pain, more frequent complaints, more interference with daily activities, and a higher degree of avoidance of activities (p<0.01) than the primary care group. When each sex was analysed separately, these differences remained for female (p<0.01) but not for male patients. Outpatients were more likely to attribute their complaints to somatic causes (p<0.01), whereas primary care patients were more likely to attribute their complaints to stress (p<0.01) or their agitated way of life (p<0.05). Multivariate analysis showed that a high severity score, a large number of additional complaints, and a low score on the stress attribution were important determinants for being in the outpatient group.Conclusions—Female outpatients consider their complaints to be more serious and interfering than do patients with IBS in primary care. Male outpatients were comparable to primary care patients with IBS. More research needs to be done into sex specific differences in IBS and into the factors that influence the decision to refer a patient with IBS.


2014 ◽  
Vol 12 (6) ◽  
pp. 953-959.e4 ◽  
Author(s):  
Shin Fukudo ◽  
Motoko Ida ◽  
Hiraku Akiho ◽  
Yoshihiro Nakashima ◽  
Kei Matsueda

2012 ◽  
Vol 142 (5) ◽  
pp. S-298
Author(s):  
Katarina Wilpart ◽  
Hans Törnblom ◽  
Jan F. Tack ◽  
Magnus Simren ◽  
Lukas Van Oudenhove

Sign in / Sign up

Export Citation Format

Share Document